Evidence map›Paper›PMID 38864667›Full record

SynthesisFuture oncology (London, England)2024

Prognostic significance of FAT10 expression in malignant tumors: a systematic review and meta-analysis.

Yi Zhang, Zheng Li, Xi Chen, Ying Huang, Bingwen Zou, Yong Xu

Abstract readMeta-AnalysisSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Future oncology (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yi ZhangDepartment of Radiation Oncology, Division of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, P.R. China.ORCID 0009-0000-5564-1209
Zheng LiDepartment of Radiation Oncology, Division of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, P.R. China.ORCID 0000-0002-8837-0318
Xi ChenDepartment of Radiation Oncology, Division of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, P.R. China.
Ying HuangCollege of Management, Sichuan Agricultural University, Chengdu, 611130, P.R. China.
Bingwen ZouDepartment of Radiation Oncology, Division of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, P.R. China.ORCID 0000-0002-0825-3657
Yong XuDepartment of Radiation Oncology, Division of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, P.R. China.

Funding

Beijing Medical Award Foundation YXJL-2021-1009-0660Clinical Research Incubation Project, West China Hospital, Sichuan University 2021HXFH022Science and Technology Department of Sichuan Province 22GJHZ0015
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorNeoplasmsUbiquitinsGene Expression Regulation, NeoplasticHumansLymphatic MetastasisNeoplasm StagingPrognosisBiomarkers, TumorUBD protein, humanUbiquitinsFAT10malignant tumorsmeta-analysisprognosticsystematic reviewtargeted therapy

Identifiers

PMID38864667
PMCPMC11441062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.